How Gender Medicine Set Itself Up for Disaster
At a closed-door meeting in 2021, ACLU attorney Chase Strangio declared, “If we take away these health care options, kids are going to die.”

In 2021, at a closed-door meeting, ACLU attorney Chase Strangio delivered a stark warning to the attendees of USPATH, the US branch of the World Professional Association for Transgender Health (WPATH). Strangio, a prominent figure in the transgender movement, warned that if healthcare options for transgender individuals were taken away, "kids are going to die." This dire prediction was made during a speech at USPATH's biennial conference, where Strangio urged healthcare providers and mental-health professionals to integrate legal and political advocacy into their work.
The central issue at the heart of Strangio's message was the demand for minors identifying as transgender to have access to gender-transition treatments, including puberty blockers, cross-sex hormones, and surgeries. This stance has been a point of contention within the transgender community, as well as in the broader healthcare and legal spheres. Strangio's speech was a call to action, urging the medical community to stand firm in supporting these treatments and to fight against any attempts to restrict access to them.
However, Strangio's vision of a dystopian future for transgender people has been more prophetic than he could have anticipated. In the years since his speech, the legal landscape for transgender individuals in the United States has become increasingly hostile. Bans on pediatric gender medicine, which at the time of the meeting had only been enacted in one state, have since spread to more than half of the US states. The Trump administration's aggressive approach to the issue has further exacerbated the challenges faced by transgender individuals and their healthcare providers.
Despite this mounting pressure, WPATH has remained resolute in its support for pediatric gender medicine. By positioning itself as the authoritative voice in caring for youth identifying as transgender, WPATH's leaders have entwined the organization's reputation with the very field it seeks to protect. As a result, the fate of pediatric gender medicine has become inextricably linked to the reputation and credibility of WPATH itself.
The pushback against gender-transition interventions for minors has come from various quarters, including state legislatures and federal agencies. Critics argue that such treatments are medically unnecessary and potentially harmful, particularly for young individuals whose developing brains may not be equipped to make informed decisions about irreversible medical procedures. They also cite concerns about the long-term psychological impacts of these treatments on minors.
In response to these criticisms, proponents of pediatric gender medicine argue that denying access to these treatments violates the fundamental rights of transgender youth to self-determination and autonomy. They contend that the physical and mental health risks associated with gender dysphoria are significant and that denying necessary care can lead to severe consequences, including suicide and self-harm.
As the debate over pediatric gender medicine continues to heat up, the stakes have never been higher. The future of transgender healthcare in the United States hangs in the balance, with the potential for catastrophic outcomes if access to these treatments is restricted. For transgender youth, the fight for healthcare access has become a battle for survival, and the warnings issued by figures like Chase Strangio serve as a stark reminder of the dire consequences that could ensue if their voices are not heard.
In the face of mounting opposition, WPATH and its allies must navigate a complex and contentious landscape. The organization's commitment to pediatric gender medicine has made it a focal point for both support and criticism, and its role in shaping the future of transgender healthcare in the United States cannot be overstated. As the legal and political battles continue, the fate of transgender youth and their access to necessary healthcare will depend on the ability of the medical community and advocates to remain steadfast in their commitment to supporting the rights and well-being of this vulnerable population.







